CENTOGENE N.V.
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better manage patient treatment. We use biological samples not only to diagnose patients; To leverage the data in the CENTOGENE Biodatabank and create value from the knowledge we have amassed over the years, we are increasingly using Artificial Intelligence (AI) tools to mine our datasets to better understand disease pathways.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2006
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Who We Are?
In a world where there are 350 million rare disease patients, we recognize that we have to do something. In a field that addresses over 7,000 rare diseases, we realize that we have to start somewhere. In an industry that has less than 5% of approved treatments, we are here to be the ones who make bold progress.
What We Do?
CENTOGENE is on a mission to enable the cure of 100 rare diseases in 10 years. At the core of everything we do? Data. Leveraging a multi-pronged method to diagnose, understand, and treat rare diseases, CENTOGENE is the leading data-driven rare disease company.
CENTOGENE SNAPSHOT
- Founded in 2006 with focus on rare, metabolic, and neurodegenerative – addressing the complete patient journey
- CENTOGENE About Us Why Choose CENTOGENE Globe Icon
- Headquarters in Rostock, Germany, with other locations in Boston, MA, Berlin, Germany, and Rotkreuz, Switzerland
- CENTOGENE Network Icon
- Rare disease-centric Biodatabank with >650,000 individuals
We are the unique and essential partner for patients, physicians, and biopharma, from diagnostics to discovery to clinical development to market access & expansion in rare, metabolic, and neurodegenerative diseases
Diagnose.
CENTOGENE’s diagnostic footprint reaches far beyond our German roots. Having diagnosed over 2,500 rare diseases across 100 countries alongside a network of over 20,000 physicians, we have been spearheading revolutionary diagnostic solutions since we were founded in 2006. We have the broadest diagnostic testing portfolio for rare diseases, covering over 19,000 genes using over 10,000 different tests. Together, we can revolutionize the early detection of rare diseases.